Related Experiment Video

Updated: May 30, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Bladder cancer: chemohyperthermia for bladder cancer--clinically effective?

Jeffrey R Gingrich

    Nature Reviews. Urology
    |July 20, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An Orthotopic Model of Murine Bladder Cancer
    09:07

    An Orthotopic Model of Murine Bladder Cancer

    Published on: February 6, 2011

    Protocol for Long Duration Whole Body Hyperthermia in Mice
    07:56

    Protocol for Long Duration Whole Body Hyperthermia in Mice

    Published on: August 25, 2012

    Related Experiment Videos

    Last Updated: May 30, 2026

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 30, 2013

    An Orthotopic Model of Murine Bladder Cancer
    09:07

    An Orthotopic Model of Murine Bladder Cancer

    Published on: February 6, 2011

    Protocol for Long Duration Whole Body Hyperthermia in Mice
    07:56

    Protocol for Long Duration Whole Body Hyperthermia in Mice

    Published on: August 25, 2012

    Related Concept Videos

    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

    Articles linked to this work by shared authors, journal, and citation graph.

    Impact of Genomic Classifiers on Risk Stratification and Treatment Intensity in Patients With Localized Prostate Cancer : A Systematic Review.

    Annals of internal medicine·2025

    Genomic classifiers and prognosis of localized prostate cancer: a systematic review.

    Prostate cancer and prostatic diseases·2024

    Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access Setting.

    Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2022

    The impact of the social construct of race on outcomes among bacille Calmette-Guérin-treated patients with high-risk non-muscle-invasive bladder cancer in an equal-access setting.

    Cancer·2021

    Associations Between Female Sex and Treatment Patterns and Outcomes for Muscle-invasive Bladder Cancer.

    Urology·2020

    Increasing use of positron emission tomography among medicare beneficiaries undergoing radical cystectomy.

    European journal of cancer care·2020

    Erectile dysfunction and cardiovascular health.

    Nature reviews. Urology·2026

    Unconventional T cells in urological cancers: catch them if you can.

    Nature reviews. Urology·2026

    Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.

    Nature reviews. Urology·2026

    The urinary microbiome, overactive bladder and bladder pain syndrome/interstitial cystitis - mechanisms, diagnostics and therapeutic opportunities.

    Nature reviews. Urology·2026

    Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer.

    Nature reviews. Urology·2026

    The role of CFTR in spermatogenesis and sperm quality.

    Nature reviews. Urology·2026

    Identifying Patients With Prostate Cancer Who Benefit Most From Routine Cardiovascular Specialist Referral.

    JACC. CardioOncology·2026

    Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial.

    Crohn's & colitis 360·2026

    Unrecognized Charcot-Marie-Tooth Disease Unmasked by Chemotherapy-Induced Neurotoxicity.

    Cureus·2026

    Intraoperative Hemodynamic Management and Cerebral Protection During Awake Craniotomy: Evidence-Based Approaches.

    Anesthesiology research and practice·2026

    Combined Enzyme-Responsive Nano-Peptide Drug with Photothermal Function for Effective Anti-Hepatocellular Carcinoma in Mice Model.

    International journal of nanomedicine·2026

    Pathologic Complete Response to Neoadjuvant Dual Checkpoint Blockade with Durvalumab Plus Tremelimumab in Advanced-Stage HCC: A Case Report.

    Journal of hepatocellular carcinoma·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us